The Marcus Corporation Returns to Profitability in the Third Quarter of Fiscal 2021
The Marcus Corporation (NYSE: MCS) reported a strong recovery in its third quarter fiscal 2021, achieving nearly $25 million in Adjusted EBITDA and positive net earnings of $1.76 million. Total revenues reached $145.86 million, a significant increase from $33.59 million in Q3 2020. Both Marcus Theatres and Marcus Hotels & Resorts outperformed their industries, with Marcus Theatres achieving positive Adjusted EBITDA for the first time since the pandemic began. The balance sheet remains solid with $197 million in cash and credit availability.
- Adjusted EBITDA of $24.51 million for Q3 2021, up from a loss of $25.81 million in Q3 2020.
- Total revenues of $145.86 million in Q3 2021, compared to $33.59 million in Q3 2020.
- Net income of $1.76 million in Q3 2021, recovering from a net loss of $39.44 million in Q3 2020.
- Marcus Theatres outperformed admission revenue compared to pre-pandemic levels by 8 percentage points.
- Marcus Hotels & Resorts reported RevPAR growth, exceeding pre-pandemic levels by approximately 10%.
- Operating loss of $55.50 million for the first three quarters of fiscal 2021, despite improvement from $123.25 million loss in the previous year.
- Adjusted net loss of $49.40 million for the first three quarters of fiscal 2021, compared to $88.69 million loss in the same period in 2020.
The Company reports positive net earnings and Adjusted EBITDA for the quarter as both
“Our results for the third quarter affirm the recovery is accelerating in both our divisions,” said
Third Quarter Fiscal 2021 Highlights
-
Total revenues for the third quarter of fiscal 2021 were
compared to total revenues of$145,862,000 for the third quarter of fiscal 2020.$33,591,000 -
Operating income was
for the third quarter of fiscal 2021, compared to operating loss of$6,273,000 for the prior year quarter.$47,987,000 -
Net income attributable to
The Marcus Corporation was for the third quarter of fiscal 2021, compared to net loss attributable to$1,759,000 The Marcus Corporation of for the same period in fiscal 2020.$39,440,000 -
Net earnings per diluted common share attributable to
The Marcus Corporation was for the third quarter of fiscal 2021, compared to net loss per diluted common share attributable to$0.06 The Marcus Corporation of for the third quarter of fiscal 2020.$1.30 -
Adjusted net earnings attributable to
The Marcus Corporation was for the third quarter of fiscal 2021, compared to Adjusted net loss attributable to$275,000 The Marcus Corporation of for the third quarter of fiscal 2020.$36,992,000 -
Adjusted net earnings per diluted common share attributable to
The Marcus Corporation was for the third quarter of fiscal 2021, compared to Adjusted net loss per diluted common share attributable to$0.01 The Marcus Corporation of for the prior year quarter.$1.22 -
Adjusted EBITDA was
for the third quarter of fiscal 2021, compared to a loss of$24,515,000 for the comparable prior year period.$25,808,000 -
Adjusted loss attributable to
The Marcus Corporation , Adjusted loss per diluted common share attributable toThe Marcus Corporation and Adjusted EBITDA reflect adjustments made by the company to eliminate the favorable impact of government grants received during the third quarter of fiscal 2021 and to eliminate the impact of a nonrecurring income tax adjustment and certain nonrecurring property closure expenses, reopening expenses and impairment charges during the third quarter of fiscal 2020.
First Three Quarters Fiscal 2021 Highlights
-
Total revenues for the first three quarters of fiscal 2021 were
compared to total revenues of$289,196,000 for the first three quarters of fiscal 2020.$200,984,000 -
Operating loss was
for the first three quarters of fiscal 2021, compared to operating loss of$55,498,000 for the first three quarters of fiscal 2020.$123,249,000 -
Net loss attributable to
The Marcus Corporation was for the first three quarters of fiscal 2021, compared to net loss attributable to$49,737,000 The Marcus Corporation of for the first three quarters of fiscal 2020.$85,821,000 -
Net loss per diluted common share attributable to
The Marcus Corporation was for the first three quarters of fiscal 2021, compared to net loss per diluted common share attributable to$1.66 The Marcus Corporation of for the first three quarters of fiscal 2020.$2.84 -
Adjusted net loss attributable to
The Marcus Corporation was for the first three quarters of fiscal 2021, compared to Adjusted net loss attributable to$49,403,000 The Marcus Corporation of for the first three quarters of fiscal 2020.$88,688,000 -
Adjusted net loss per diluted common share attributable to
The Marcus Corporation was for the first three quarters of fiscal 2021, compared to Adjusted net loss per diluted common share attributable to$1.64 The Marcus Corporation of for the first three quarters of fiscal 2020.$2.93 -
Adjusted EBITDA was
for the first three quarters of fiscal 2021, compared to a loss of$5,830,000 for the first three quarters of fiscal 2020.$43,804,000 -
Adjusted loss attributable to
The Marcus Corporation , Adjusted loss per diluted common share attributable toThe Marcus Corporation and Adjusted EBITDA reflect adjustments made by the company to eliminate the favorable impact of government grants received and the impact of impairment charges during the first three quarters of fiscal 2021, as well as the impact of a favorable income tax adjustment and certain nonrecurring property closure expenses, reopening expenses and impairment charges during the first three quarters of fiscal 2020.
Bolstered by increasing vaccination rates, improving consumer confidence and the release of a greater number of high-performing new films, the division’s operating loss improved significantly in the third quarter of fiscal 2021. For the first time since the pandemic began,
Comparing admission revenues to pre-pandemic fiscal 2019 results,
“We are optimistic about the continuing rebound in the movie theatre industry and at
The highest grossing films in the fiscal 2021 third quarter included “Black Widow,” “Shang-Chi and the Legend of the Ten Rings,” “Jungle Cruise,” “Free Guy,” and “Space Jam: A New Legacy.” Momentum continued into October, as the division experienced its best month at the box office in the COVID era, with films such as “Venom: Let There Be Carnage,” “The Addams Family 2,” “No Time to Die,” “Halloween Kills,” and “Dune” contributing to early fourth quarter results. Highly anticipated new films scheduled for release in the remainder of the fourth quarter of fiscal 2021 include “Eternals,” “Ghostbusters: Afterlife,” “King Richard,” “Encanto,” “West Side Story,” “Spider-Man: No Way Home,” “Sing 2,” “The Kings Man,” and “The Matrix Resurrections.” Looking ahead to 2022, the film slate is expected to remain very strong, including a long list of familiar titles and franchises.
Comparing RevPAR to pre-pandemic fiscal 2019 results,
“Our operating results significantly exceeded expectations during the quarter,” said
Group booking pace for fiscal 2022, while still behind the pre-pandemic pace, has meaningfully improved from earlier in the year. Increased booking activity has extended into the fourth quarter of fiscal 2021. Banquet and catering booking pace, while also behind pre-pandemic levels, continues to benefit from increases in wedding bookings.
Balance Sheet and Liquidity
The Marcus Corporation’s financial position remains strong, with
“As has been the case throughout our 86-year history, our strong liquidity and low debt has positioned us well during various economic cycles,” said
In the third quarter of fiscal 2021 the company realized additional proceeds from the sale of non-core real estate assets and increased the number of additional non-core assets under either letter of intent or contract to sell. The company also anticipates the receipt of expected income tax refunds in the fourth quarter of fiscal 2021.
Conference Call and Webcast
1-574-990-3059 and entering the passcode 6594275. Listeners should dial in to the call at least 5-10 minutes prior to the start of the call or should go to the website at least 15 minutes prior to the call to download and install any necessary audio software.
A telephone replay of the conference call will be available through
Non-GAAP Financial Measures
Adjusted net earnings (loss) attributable to
Adjusted net earnings (loss) attributable to
Adjusted net earnings (loss) attributable to
About
Headquartered in
Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects of the COVID-19 pandemic on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the duration of the COVID-19 pandemic and related government restrictions and social distancing requirements and the level of customer demand following the relaxation of such requirements; (3) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (particularly following the COVID-19 pandemic, during which the production of new movie content temporarily ceased and release dates for motion pictures have been postponed), as well as other industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets, including but not limited to, those caused by the COVID-19 pandemic; (5) the effects of adverse economic conditions, including but not limited to, those caused by the COVID-19 pandemic, on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the COVID-19 pandemic and the effects on our occupancy and room rates of the relative industry supply of available rooms at comparable lodging facilities in our markets once hotels and resorts have more fully reopened; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (11) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (12) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in
Consolidated Statements of Earnings (Loss) | ||||||||||||||||
(Unaudited) | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
13 Weeks Ended | 39 Weeks Ended | |||||||||||||||
2021 |
2020 |
2021 |
2020 |
|||||||||||||
Revenues: | ||||||||||||||||
Theatre admissions | $ |
38,250 |
|
$ |
3,118 |
|
$ |
73,850 |
|
$ |
58,667 |
|
||||
Rooms |
|
30,917 |
|
|
9,772 |
|
|
57,293 |
|
|
27,618 |
|
||||
Theatre concessions |
|
35,952 |
|
|
3,243 |
|
|
68,932 |
|
|
50,277 |
|
||||
Food and beverage |
|
16,731 |
|
|
5,420 |
|
|
32,234 |
|
|
19,620 |
|
||||
Other revenues |
|
19,128 |
|
|
8,813 |
|
|
45,253 |
|
|
30,886 |
|
||||
|
140,978 |
|
|
30,366 |
|
|
277,562 |
|
|
187,068 |
|
|||||
Cost reimbursements |
|
4,884 |
|
|
3,225 |
|
|
11,634 |
|
|
13,916 |
|
||||
Total revenues |
|
145,862 |
|
|
33,591 |
|
|
289,196 |
|
|
200,984 |
|
||||
Costs and expenses: | ||||||||||||||||
Theatre operations |
|
40,513 |
|
|
14,150 |
|
|
87,660 |
|
|
76,806 |
|
||||
Rooms |
|
9,682 |
|
|
4,611 |
|
|
22,019 |
|
|
16,132 |
|
||||
Theatre concessions |
|
15,094 |
|
|
2,592 |
|
|
29,627 |
|
|
25,634 |
|
||||
Food and beverage |
|
12,344 |
|
|
5,109 |
|
|
25,520 |
|
|
20,725 |
|
||||
Advertising and marketing |
|
4,827 |
|
|
1,981 |
|
|
11,195 |
|
|
8,446 |
|
||||
Administrative |
|
16,536 |
|
|
11,645 |
|
|
45,815 |
|
|
40,555 |
|
||||
Depreciation and amortization |
|
17,730 |
|
|
18,690 |
|
|
54,203 |
|
|
56,568 |
|
||||
Rent |
|
6,544 |
|
|
6,594 |
|
|
19,229 |
|
|
19,876 |
|
||||
Property taxes |
|
4,935 |
|
|
5,950 |
|
|
14,142 |
|
|
18,004 |
|
||||
Other operating expenses |
|
6,500 |
|
|
6,266 |
|
|
19,918 |
|
|
18,094 |
|
||||
Impairment charges |
|
- |
|
|
765 |
|
|
3,732 |
|
|
9,477 |
|
||||
Reimbursed costs |
|
4,884 |
|
|
3,225 |
|
|
11,634 |
|
|
13,916 |
|
||||
Total costs and expenses |
|
139,589 |
|
|
81,578 |
|
|
344,694 |
|
|
324,233 |
|
||||
Operating income (loss) |
|
6,273 |
|
|
(47,987 |
) |
|
(55,498 |
) |
|
(123,249 |
) |
||||
Other income (expense): | ||||||||||||||||
Investment income (loss) |
|
(7 |
) |
|
66 |
|
|
153 |
|
|
207 |
|
||||
Interest expense |
|
(4,600 |
) |
|
(4,132 |
) |
|
(14,350 |
) |
|
(10,177 |
) |
||||
Other expense |
|
(625 |
) |
|
(590 |
) |
|
(1,881 |
) |
|
(1,771 |
) |
||||
Gain (loss) on disposition of property, equipment and other assets |
|
868 |
|
|
(251 |
) |
|
2,908 |
|
|
(299 |
) |
||||
Equity losses from unconsolidated joint ventures |
|
- |
|
|
(1,054 |
) |
|
- |
|
|
(1,539 |
) |
||||
|
(4,364 |
) |
|
(5,961 |
) |
|
(13,170 |
) |
|
(13,579 |
) |
|||||
Earnings (loss) before income taxes |
|
1,909 |
|
|
(53,948 |
) |
|
(68,668 |
) |
|
(136,828 |
) |
||||
Income tax expense (benefit) |
|
150 |
|
|
(14,508 |
) |
|
(18,931 |
) |
|
(50,984 |
) |
||||
Net earnings (loss) attributable to |
|
1,759 |
|
|
(39,440 |
) |
|
(49,737 |
) |
|
(85,844 |
) |
||||
Net loss attributable to noncontrolling interests |
|
- |
|
|
- |
|
|
- |
|
|
(23 |
) |
||||
Net earnings (loss) attributable to |
$ |
1,759 |
|
$ |
(39,440 |
) |
$ |
(49,737 |
) |
$ |
(85,821 |
) |
||||
Net earnings (loss) per common share attributable to | ||||||||||||||||
$ |
0.06 |
|
$ |
(1.30 |
) |
$ |
(1.66 |
) |
$ |
(2.84 |
) |
|||||
Weighted average shares outstanding - diluted |
|
31,469 |
|
|
31,064 |
|
|
31,340 |
|
|
31,033 |
|
Condensed Consolidated Balance Sheets | |||||
(In thousands) | |||||
(Unaudited) | (Audited) | ||||
2021 |
2020 |
||||
Assets: | |||||
Cash and cash equivalents | $ |
8,629 |
$ |
6,745 |
|
Restricted cash |
|
6,346 |
|
7,343 |
|
Accounts receivable |
|
18,808 |
|
6,359 |
|
Government grants receivable |
|
- |
|
4,913 |
|
Refundable income taxes |
|
23,051 |
|
27,934 |
|
Assets held for sale |
|
12,773 |
|
4,117 |
|
Other current assets |
|
14,360 |
|
10,406 |
|
Property and equipment, net |
|
787,267 |
|
848,328 |
|
Operating lease right-of-use assets |
|
220,556 |
|
229,660 |
|
Other assets |
|
97,256 |
|
108,373 |
|
Total Assets | $ |
1,189,046 |
$ |
1,254,178 |
|
Liabilities and Shareholders' Equity: | |||||
Accounts payable | $ |
21,141 |
$ |
13,158 |
|
Taxes other than income taxes |
|
17,277 |
|
18,308 |
|
Other current liabilities |
|
68,650 |
|
65,787 |
|
Short-term borrowings |
|
49,796 |
|
87,194 |
|
Current portion of finance lease obligations |
|
2,666 |
|
2,783 |
|
Current portion of operating lease obligations |
|
17,010 |
|
19,614 |
|
Current maturities of long-term debt |
|
11,712 |
|
10,548 |
|
Finance lease obligations |
|
17,796 |
|
19,744 |
|
Operating lease obligations |
|
220,075 |
|
230,550 |
|
Long-term debt |
|
236,611 |
|
193,036 |
|
Deferred income taxes |
|
22,061 |
|
33,429 |
|
Other long-term obligations |
|
61,945 |
|
61,304 |
|
Equity |
|
442,306 |
|
498,723 |
|
Total Liabilities and Shareholders' Equity | $ |
1,189,046 |
$ |
1,254,178 |
Business Segment Information | ||||||||||||||||
(Unaudited) | ||||||||||||||||
(In thousands) | ||||||||||||||||
Theatres | Hotels/ Resorts |
Corporate Items |
Total | |||||||||||||
13 Weeks Ended |
||||||||||||||||
Revenues | $ |
79,996 |
|
$ |
65,803 |
|
$ |
63 |
|
$ |
145,862 |
|
||||
Operating income (loss) |
|
(2,604 |
) |
|
13,458 |
|
|
(4,581 |
) |
|
6,273 |
|
||||
Depreciation and amortization |
|
12,636 |
|
|
5,018 |
|
|
76 |
|
|
17,730 |
|
||||
13 Weeks Ended |
||||||||||||||||
Revenues | $ |
7,354 |
|
$ |
26,178 |
|
$ |
59 |
|
$ |
33,591 |
|
||||
Operating loss |
|
(37,174 |
) |
|
(6,925 |
) |
|
(3,888 |
) |
|
(47,987 |
) |
||||
Depreciation and amortization |
|
13,353 |
|
|
5,210 |
|
|
127 |
|
|
18,690 |
|
||||
39 Weeks Ended |
||||||||||||||||
Revenues | $ |
154,859 |
|
$ |
134,079 |
|
$ |
258 |
|
$ |
289,196 |
|
||||
Operating income (loss) |
|
(46,458 |
) |
|
5,511 |
|
|
(14,551 |
) |
|
(55,498 |
) |
||||
Depreciation and amortization |
|
38,807 |
|
|
15,192 |
|
|
204 |
|
|
54,203 |
|
||||
39 Weeks Ended |
||||||||||||||||
Revenues | $ |
118,414 |
|
$ |
82,253 |
|
$ |
317 |
|
$ |
200,984 |
|
||||
Operating loss |
|
(78,788 |
) |
|
(32,459 |
) |
|
(12,002 |
) |
|
(123,249 |
) |
||||
Depreciation and amortization |
|
40,245 |
|
|
15,955 |
|
|
368 |
|
|
56,568 |
|
||||
Corporate items include amounts not allocable to the business segments. Corporate revenues consist | ||||||||||||||||
principally of rent and the corporate operating loss includes general corporate expenses. Corporate | ||||||||||||||||
information technology costs and accounting shared services costs are allocated to the business segments | ||||||||||||||||
based upon several factors, including actual usage and segment revenues. | ||||||||||||||||
Supplemental Data | ||||||||||||||||
(Unaudited) | ||||||||||||||||
(In thousands) | ||||||||||||||||
13 Weeks Ended | 39 Weeks Ended | |||||||||||||||
Consolidated | 2021 |
2020 |
2021 |
2020 |
||||||||||||
Net cash flow provided by (used in) operating activities | $ |
11,738 |
|
$ |
(25,633 |
) |
$ |
2,057 |
|
$ |
(80,649 |
) |
||||
Net cash flow provided by (used in) investing activities |
|
12,993 |
|
|
(2,570 |
) |
|
9,248 |
|
|
(11,709 |
) |
||||
Net cash flow provided by (used in) financing activities |
|
(24,886 |
) |
|
(43,025 |
) |
|
(10,418 |
) |
|
83,493 |
|
||||
Capital expenditures |
|
(2,926 |
) |
|
(2,802 |
) |
|
(9,121 |
) |
|
(18,687 |
) |
||||
Reconciliation of Adjusted net earnings (loss) and Adjusted net earnings (loss) per diluted common share | |||||||||||||||
(Unaudited) | |||||||||||||||
(In thousands, except per share data) | |||||||||||||||
13 Weeks Ended | 39 Weeks Ended | ||||||||||||||
2021 |
2020 |
2021 |
2020 |
||||||||||||
Net earnings (loss) attributable to |
$ |
1,759 |
|
$ |
(39,440 |
) |
$ |
(49,737 |
) |
$ |
(85,821 |
) |
|||
Add (deduct): | |||||||||||||||
Adjustment to income taxes (a) |
|
168 |
|
|
(17,420 |
) |
|||||||||
Property closure/reopening expenses - theatres (b) |
|
- |
|
|
1,173 |
|
|
- |
|
|
4,630 |
|
|||
Property closure/reopening expenses - hotels (c) |
|
- |
|
|
443 |
|
|
- |
|
|
5,484 |
|
|||
Impairment charges (d) |
|
- |
|
|
765 |
|
|
3,732 |
|
|
9,477 |
|
|||
Joint venture impairment charge (e) |
|
811 |
|
|
811 |
|
|||||||||
Government grants (f) |
|
(2,009 |
) |
|
- |
|
|
(3,280 |
) |
|
- |
|
|||
Tax impact of adjustments to net earnings (g) |
|
525 |
|
|
(912 |
) |
|
(118 |
) |
|
(5,849 |
) |
|||
Adjusted net earnings (loss) attributable to |
$ |
275 |
|
$ |
(36,992 |
) |
$ |
(49,403 |
) |
$ |
(88,688 |
) |
|||
Weighted average shares outstanding - diluted |
|
31,469 |
|
|
31,064 |
|
|
31,340 |
|
|
31,033 |
|
|||
Net earnings (loss) per diluted common share attributable to |
$ |
0.06 |
|
$ |
(1.30 |
) |
$ |
(1.66 |
) |
$ |
(2.84 |
) |
|||
Adjusted net earnings (loss) per diluted common share attributable to |
$ |
0.01 |
|
$ |
(1.22 |
) |
$ |
(1.64 |
) |
$ |
(2.93 |
) |
|||
(a) Reflects a nonrecurring adjustment to income taxes related to several accounting method changes and the impact of the CARES Act, which allows net operating loss carrybacks to a higher federal income tax rate year. | |||||||||||||||
(b) Reflects nonrecurring costs related to the required closure of all of the company's movie theatres due to the COVID-19 pandemic, plus subsequent nonrecurring costs related to reopening theatres. | |||||||||||||||
(c) Reflects nonrecurring costs related to the closure of the company's hotels and resorts due to reduced occupancy as a result of the COVID-19 pandemic, plus subsequent nonrecurring costs related to reopening hotels. | |||||||||||||||
(d) Impairment charges related to surplus theatre real estate for the fiscal 2021 periods and intangible assets (trade name) and several theatre locations for the fiscal 2020 periods. | |||||||||||||||
(e) Impairment charge related to an investment in a joint venture | |||||||||||||||
(f) Reflects nonrecurring state government grants awarded to our theatres and hotels for COVID-19 relief. | |||||||||||||||
(g) Represents the tax effect related to adjustments (b), (c), (d), (e) and (f) to net earnings (loss), calculated using a statutory tax rate of |
|||||||||||||||
Reconciliation of Net earnings (loss) to Adjusted EBITDA | |||||||||||||||
(Unaudited) | |||||||||||||||
(In thousands) | |||||||||||||||
13 Weeks Ended |
39 Weeks Ended |
||||||||||||||
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Net earnings (loss) attributable to |
$ |
1,759 |
|
$ |
(39,440 |
) |
$ |
(49,737 |
) |
$ |
(85,821 |
) |
|||
Add (deduct): | |||||||||||||||
Investment income |
|
7 |
|
|
(66 |
) |
|
(153 |
) |
|
(207 |
) |
|||
Interest expense |
|
4,600 |
|
|
4,132 |
|
|
14,350 |
|
|
10,177 |
|
|||
Other expense |
|
625 |
|
|
590 |
|
|
1,881 |
|
|
1,771 |
|
|||
(Gain) loss on disposition of property, equipment and other assets |
|
(868 |
) |
|
251 |
|
|
(2,908 |
) |
|
299 |
|
|||
Equity losses from unconsolidated joint ventures |
|
- |
|
|
1,054 |
|
|
- |
|
|
1,539 |
|
|||
Net loss attributable to noncontrolling interests |
|
- |
|
|
0 |
|
|
0 |
|
|
(23 |
) |
|||
Income tax expense (benefit) |
|
150 |
|
|
(14,508 |
) |
|
(18,931 |
) |
|
(50,984 |
) |
|||
Depreciation and amortization |
|
17,730 |
|
|
18,690 |
|
|
54,203 |
|
|
56,568 |
|
|||
Share-based compensation expenses (a) |
|
2,521 |
|
|
1,108 |
|
|
6,673 |
|
|
3,286 |
|
|||
Property closure/reopening expenses - theatres (b) |
|
- |
|
|
1,173 |
|
|
- |
|
|
4,630 |
|
|||
Property closure/reopening expenses - hotels (c) |
|
- |
|
|
443 |
|
|
- |
|
|
5,484 |
|
|||
Impairment charges (d) |
|
- |
|
|
765 |
|
|
3,732 |
|
|
9,477 |
|
|||
Government grants (e) |
|
(2,009 |
) |
|
- |
|
|
(3,280 |
) |
|
- |
|
|||
Adjusted EBITDA | $ |
24,515 |
|
$ |
(25,808 |
) |
$ |
5,830 |
|
$ |
(43,804 |
) |
|||
(a) Non-cash charges related to share-based compensation programs. | |||||||||||||||
(b) Reflects nonrecurring costs (primarily payroll) related to the required closure of all of the company's movie theatres due to the COVID-19 pandemic, plus subsequent nonrecurring costs related to reopening theatres. | |||||||||||||||
(c) Reflects nonrecurring costs related to the closure of the company's hotels and resorts due to reduced occupancy as a result of the COVID-19 pandemic, plus subsequent nonrecurring costs related to reopening hotels. | |||||||||||||||
(d) Impairment charges related to surplus theatre real estate for the fiscal 2021 periods and intangible assets (trade name) and several theatre locations for the fiscal 2020 periods. | |||||||||||||||
(e) Reflects nonrecurring state government grants awarded to our theatres and hotels for COVID-19 relief. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211103005167/en/
(414) 905-1100
Source:
FAQ
What were the earnings results for Marcus Corporation in Q3 2021?
How did Marcus Theatres perform compared to industry trends in Q3 2021?
What is the revenue growth for Marcus Corporation in fiscal 2021?